Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
Go back to Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products| SIMULATIONS PLUS, Inc. (NASDAQ: SLP) | Delayed: 18.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.15 | 52 Week High | $11.89 | |||
| Open | $18.15 | 52 Week Low | $6.74 | |||
| Day High | $18.15 | P/E | 100.83 | |||
| Day Low | $18.15 | EPS | $0.18 | |||
| Volume | 2 | |||||
